Telephone
61.3.5339.0704
Address
Level 9 Suite 9.02 45 William Street Melbourne, Victoria (VIC) 3000
Description
Integral Diagnostics Ltd. engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied professionals. It operates under three core brands: Lake Imaging, South Coast Radiology, and Global Diagnostics. The company was founded on April 29, 2008 and is headquartered in North Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 1.64 - 3.54
Trade Value (12mth)
AU$314,981.00
1 week
-0.58%
1 month
-35.47%
YTD
-42.23%
1 year
-36.9%
All time high
5.47376
EPS 3 yr Growth
-12.200%
EBITDA Margin
19.00%
Operating Cashflow
$71m
Free Cash Flow Return
10.30%
ROIC
3.60%
Interest Coverage
4.60
Quick Ratio
0.80
Shares on Issue (Fully Dilluted)
236m
HALO Sector
Healthcare
Next Company Report Date
26-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
2.78
Date | Announcements |
---|---|
31 January 22 |
Becoming a substantial holder
×
Becoming a substantial holder |
31 August 22 |
Change of Director's Interest Notice - Jacqueline Milne
×
Change of Director's Interest Notice - Jacqueline Milne |
31 August 22 |
Release from Escrow
×
Release from Escrow |
30 September 21 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
30 October 23 |
4DX: 4DMedical enters contract with Integral Diagnostics
×
4DX: 4DMedical enters contract with Integral Diagnostics |
30 October 20 |
Chairman's Address and CEO/MD Presentation to Shareholders
×
Chairman's Address and CEO/MD Presentation to Shareholders |
30 October 20 |
Results of Annual General Meeting
×
Results of Annual General Meeting |
30 November 23 |
Final Director's Interest Notice - Helen Kurincic
×
Final Director's Interest Notice - Helen Kurincic |
30 November 23 |
Notification regarding unquoted securities - IDX
×
Notification regarding unquoted securities - IDX |
30 August 23 |
Initial Director's Interest Notice - Ingrid Player
×
Initial Director's Interest Notice - Ingrid Player |
30 April 19 |
Presentation to Macquarie Equities Conference
×
Presentation to Macquarie Equities Conference |
29 September 22 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
29 November 23 |
AGM Address and Presentation by Chair and CEO
×
AGM Address and Presentation by Chair and CEO |
29 November 23 |
Becoming a substantial holder
×
Becoming a substantial holder |
29 November 23 |
Results of Annual General Meeting
×
Results of Annual General Meeting |
29 November 17 |
CAJ: Presentation - Capitol's Offer for Integral Diagnostics
×
CAJ: Presentation - Capitol's Offer for Integral Diagnostics |
29 June 22 |
Appendix 3B
×
Appendix 3B |
29 June 22 |
Appendix 2A
×
Appendix 2A |
29 June 22 |
Application for quotation of securities - IDX
×
Application for quotation of securities - IDX |
29 July 20 |
2020 Annual General Meeting
×
2020 Annual General Meeting |
29 December 21 |
Appointment of Chief Financial Officer
×
Appointment of Chief Financial Officer |
29 August 23 |
Notification of cessation of securities - IDX
×
Notification of cessation of securities - IDX |
29 August 23 |
Change of Director's Interest Notice - Ian Kadish
×
Change of Director's Interest Notice - Ian Kadish |
29 August 22 |
Appendix 4E and Annual Report to shareholders
×
Appendix 4E and Annual Report to shareholders |
29 August 22 |
Dividend/Distribution - IDX
×
Dividend/Distribution - IDX |
29 August 22 |
FY22 Results Announcement
×
FY22 Results Announcement |
29 August 22 |
FY22 Investor Presentation
×
FY22 Investor Presentation |
29 August 22 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.